IL1RL1 and cancer: Replication analyses were performed for all circulating inflammatory marker-cancer associations with strong or suggestive evidence except for interleukin-1 receptor-like 1 and triple-negative breast cancer risk where summary genetic association data could not be identified for this cancer outcome in the FinnGen study or in alternate independent datasets.